Promotion of cooperation between enterprises and the public. Research institutions in R & D & I (Q3304849): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Added qualifier: readability score (P590521): 0.0061547098693049)
(‎Set a claim value: summary (P836): Desenvolvimento de uma previsão para o benefício da aférese em doentes com esclerose múltipla (EM) em impulso agudo. Para esta finalidade, os jogos diagnósticos são desenvolvidos que distinguem respondedores dos não-respondedores para a terapia da plamaférese.)
 
Property / summaryProperty / summary
Desenvolvimento de uma previsão para o benefício da aférese em pacientes com esclerose múltipla (EM) em impulso agudo. Para este efeito, são desenvolvidos kits de diagnóstico que distinguem os respondedores dos não-respondentes à terapia com plamapherese. (Portuguese)
Desenvolvimento de uma previsão para o benefício da aférese em doentes com esclerose múltipla (EM) em impulso agudo. Para esta finalidade, os jogos diagnósticos são desenvolvidos que distinguem respondedores dos não-respondedores para a terapia da plamaférese. (Portuguese)

Latest revision as of 23:36, 9 October 2024

Project Q3304849 in Germany
Language Label Description Also known as
English
Promotion of cooperation between enterprises and the public. Research institutions in R & D & I
Project Q3304849 in Germany

    Statements

    country
    Germany
    0 references
    EU contribution
    656,244.0 Euro
    0 references
    budget
    820,305.0 Euro
    0 references
    co-financing rate
    80.0 percent
    0 references
    start time
    28 September 2017
    0 references
    end time
    30 June 2023
    0 references
    beneficiary name (string)
    Miltenyi Biotec GmbH Niederlassung Teterow
    0 references
    beneficiary
    Q3363042
    0 references
    coordinate location

    53°46'17.22"N, 12°34'24.67"E
    0 references
    postal code
    17166 - Teterow
    0 references
    summary
    Entwicklung einer Vorhersagemöglichkeit für den Nutzen der Apherese bei Multiple Sklerose (MS) Patienten im akuten Schub. Dazu werden diagnostische Kits entwickelt, die Responder von Non-Respondern für die Plamapherese-Therapie unterscheiden. (German)
    0 references
    Development of a prediction for the benefit of apheresis in multiple sclerosis (MS) patients in acute thrust. For this purpose, diagnostic kits are developed that distinguish responders from non-responders for plamapheresis therapy. (English)
    point in time
    24 October 2021
    readability score
    0.0061547098693049
    0 references
    Développement d’une prédiction des bénéfices de l’aphérèse chez les patients atteints de sclérose en plaques (MS) dans la poussée aiguë. Pour ce faire, des kits de diagnostic sont mis au point, qui distinguent les répondeurs des non-répondeurs pour le traitement de la Plamapherese. (French)
    point in time
    6 December 2021
    0 references
    Ontwikkeling van een voorspelling ten behoeve van aferese bij patiënten met multiple sclerose (MS) in acute stuwkracht. Voor dit doel worden diagnostische kits ontwikkeld die responders onderscheiden van non-responders voor plamaferesetherapie. (Dutch)
    point in time
    19 December 2021
    0 references
    Sviluppo di una previsione a beneficio dell'aferesi nei pazienti con sclerosi multipla (MS) in spinta acuta. A tal fine, vengono sviluppati kit diagnostici che distinguono i rispondenti dai non rispondenti per la terapia con plamaferesi. (Italian)
    point in time
    18 January 2022
    0 references
    Desarrollo de una predicción para el beneficio de la aféresis en pacientes con esclerosis múltiple (EM) en empuje agudo. Para este propósito, se desarrollan kits de diagnóstico que distinguen a los respondedores de los no respondedores para la terapia de plamaféresis. (Spanish)
    point in time
    22 January 2022
    0 references
    Afereesi kasulikkuse prognoosi väljatöötamine hulgiskleroosiga patsientidel ägeda tõukejõu korral. Selleks töötatakse välja diagnostilised komplektid, mis eristavad reageerijaid plamaphereesi ravile mittereageerijatest. (Estonian)
    point in time
    5 August 2022
    0 references
    Aferezės naudos prognozavimas pacientams, sergantiems ūmine trauka išsėtine skleroze (IS). Šiuo tikslu kuriami diagnostiniai rinkiniai, kurie skiria atsaką į gydymą plamaferezės gydymui nereagavusius asmenis. (Lithuanian)
    point in time
    5 August 2022
    0 references
    Razvoj predviđanja u korist afereze u bolesnika s multiplom sklerozom (MS) u akutnom potisku. U tu se svrhu razvijaju dijagnostički kompleti koji razlikuju osobe koje reagiraju na liječenje plamaferezom od onih koji nisu odgovorili na liječenje plamaferezom. (Croatian)
    point in time
    5 August 2022
    0 references
    Ανάπτυξη πρόβλεψης προς όφελος της αφαίρεσης σε ασθενείς με σκλήρυνση κατά πλάκας (MS) σε οξεία ώση. Για το σκοπό αυτό, αναπτύσσονται διαγνωστικά κιτ που διακρίνουν τους ανταποκριτές από τους μη ανταποκριτές για θεραπεία με πλαταφαίρεση. (Greek)
    point in time
    5 August 2022
    0 references
    Vývoj predpovede v prospech aferézy u pacientov so sklerózou multiplex (MS) v akútnom ťahu. Na tento účel sa vyvíjajú diagnostické súpravy, ktoré odlišujú pacientov reagujúcich na liečbu plamaferézou od pacientov, ktorí neodpovedali na liečbu plamaferézou. (Slovak)
    point in time
    5 August 2022
    0 references
    Ennusteen kehittäminen afereesin hyödyksi multippeliskleroosipotilailla akuutissa työntövoimassa. Tätä tarkoitusta varten kehitetään diagnostisia sarjoja, jotka erottavat vasteen saaneet plamafereesihoitoihin osallistumattomista potilaista. (Finnish)
    point in time
    5 August 2022
    0 references
    Opracowanie prognozy na korzyść aferezy u pacjentów ze stwardnieniem rozsianym (MS) w ostrym ciągu. W tym celu opracowano zestawy diagnostyczne, które odróżniają osoby odpowiadające od osób niereagujących na terapię plamaferezą. (Polish)
    point in time
    5 August 2022
    0 references
    Az akut tolóerőben lévő sclerosis multiplexben (MS) szenvedő betegek apheresis előnyére vonatkozó előrejelzés kidolgozása. Erre a célra olyan diagnosztikai készleteket fejlesztenek ki, amelyek megkülönböztetik a válaszadókat a nem válaszadóktól a plamapheresis terápia esetében. (Hungarian)
    point in time
    5 August 2022
    0 references
    Vývoj predikce ve prospěch aferézy u pacientů s roztroušenou sklerózou (MS) v akutním tahu. Za tímto účelem jsou vyvinuty diagnostické soupravy, které odlišují respondenty od non-respondérů pro léčbu plamaferézou. (Czech)
    point in time
    5 August 2022
    0 references
    Prognozes izstrāde aferēzes ieguvumu multiplās sklerozes (MS) pacientiem akūtas vilces gadījumā. Šim nolūkam tiek izstrādāti diagnostikas komplekti, kas nošķir pacientus, kuriem nav atbildes reakcijas, plamaferēzes terapijā. (Latvian)
    point in time
    5 August 2022
    0 references
    Tuar a fhorbairt ar mhaithe le haoirí i il-othair scléaróise (MS) a bhfuil géarsá orthu. Chun na críche sin, forbraítear trealamh diagnóiseach a dhéanann idirdhealú ar fhreagróirí ó neamh-fhreagróirí do theiripe plamapheresis. (Irish)
    point in time
    5 August 2022
    0 references
    Razvoj napovedi v korist afereze pri bolnikih z multiplo sklerozo (MS) v akutni potisk. V ta namen so pripravljeni diagnostični kompleti, ki razlikujejo bolnike, ki so se odzvali na zdravljenje s plamaferezo, od tistih, ki se niso odzvali na zdravljenje s plamaferezo. (Slovenian)
    point in time
    5 August 2022
    0 references
    Разработване на прогноза в полза на аферезата при пациенти с множествена склероза (МС) с остра тяга. За тази цел се разработват диагностични комплекти, които отличават респондентите от тези, които не отговарят на терапията с пламафереза. (Bulgarian)
    point in time
    5 August 2022
    0 references
    Żvilupp ta’ tbassir għall-benefiċċju ta’ aferesi f’pazjenti bi sklerożi multipla (MS) f’forza propulsiva akuta. Għal dan il-għan, jiġu żviluppati kits dijanjostiċi li jiddistingwu lil dawk li rrispondew minn dawk li ma rrispondewx għat-terapija tal-plamapheresi. (Maltese)
    point in time
    5 August 2022
    0 references
    Desenvolvimento de uma previsão para o benefício da aférese em doentes com esclerose múltipla (EM) em impulso agudo. Para esta finalidade, os jogos diagnósticos são desenvolvidos que distinguem respondedores dos não-respondedores para a terapia da plamaférese. (Portuguese)
    point in time
    5 August 2022
    0 references
    Udvikling af en forudsigelse til fordel for aferese hos multipel sklerose (MS) patienter med akut tryk. Til dette formål udvikles diagnostiske kits, der adskiller respondenter fra ikke-respondenter til behandling med plamaferese. (Danish)
    point in time
    5 August 2022
    0 references
    Dezvoltarea unei predicții în beneficiul aferezei la pacienții cu scleroză multiplă (SM) cu tracțiune acută. În acest scop, sunt elaborate kituri de diagnosticare care să distingă respondenții de cei care nu au răspuns la tratament pentru terapia cu plamafereză. (Romanian)
    point in time
    5 August 2022
    0 references
    Utveckling av en prediktion till förmån för aferes hos patienter med multipel skleros (MS) i akut dragkraft. För detta ändamål utvecklas diagnostiska kit som skiljer responders från icke-responders för plamaferes terapi. (Swedish)
    point in time
    5 August 2022
    0 references

    Identifiers

    German Kohesio ID
    DE_TEMPORARY_7634
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3304849&oldid=43110292"